National Cancer Institute; Notice of Closed Meetings, 1377-1378 [2018-00297]

Download as PDF Federal Register / Vol. 83, No. 8 / Thursday, January 11, 2018 / Notices Contact Person: Chee Lim, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4128, Bethesda, MD 20892, 301– 435–1850, limc4@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Academic Research Enhancement Award. Date: February 16, 2018. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Inna Gorshkova, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301–435–1784, gorshkoi@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: January 8, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–00388 Filed 1–10–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings srobinson on DSK9F5VC42PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant and/or contract proposals applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant and/or contract proposals applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel TEP–9B: Cancer Cachexia Therapy. Date: February 6, 2018. Time: 10:00 a.m. to 12:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference Call). VerDate Sep<11>2014 00:05 Jan 11, 2018 Jkt 244001 Contact Person: Jun Fang, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W246, Bethesda, MD 20892–9750, 240–276–5460, jfang@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Development of Informatics Technologies for Cancer Research and Management. Date: February 8–9, 2018. Time: 5:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Cambria Hotel & Suites Rockville, 1 Helen Henghan Way, Rockville, MD 20892. Contact Person: Saejeong J. Kim, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W640, Bethesda, MD 20892–9750, 240–276–5179, saejeong.kim@ nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Program Project V (P01) Review. Date: February 14–15, 2018. Time: 5:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878. Contact Person: Wlodek Lopaczynski, MD, Ph.D., Scientific Review Officer, Office of the Director, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W514, Bethesda, MD 20892–9750, 240–276–6340, lopacw@ mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Innovative Molecular Analysis Technologies (IMAT). Date: February 15, 2018. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Yasuko Furumoto, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W424, Bethesda, MD 20892– 9750, 240–276–5287, yasuko.furumoto@ nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Pancreatic Cancer Detection Consortium (U01). Date: February 15, 2018. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W240, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Hasan Siddiqui, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH 9609, Medical Center Drive, Room 7W240, Bethesda, MD PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 1377 20892–9750, 240–276–5122, hasan.siddiqui@ nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–5A: NCI Clinical and Translational Exploratory/ Developmental Studies. Date: February 15, 2018. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W238, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W238, Bethesda, MD 20892–9750, 240–276–7755, byeong-chel.lee@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; UH2 Review. Date: February 27, 2018. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W608, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Robert E. Bird, Ph.D., Scientific Review Officer, Research Program Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W608, Bethesda, MD 20892–9750, 240–276–6344, birdr@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; R25 Review. Date: February 28, 2018. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W608, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Robert E. Bird, Ph.D., Scientific Review Officer, Research Program Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W608, Bethesda, MD 20892–9750, 240–276–6344, birdr@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; R01 MultiSite. Date: March 6, 2018. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W608, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Robert E. Bird, Ph.D., Scientific Review Officer, Research Program Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W608, Bethesda, MD 20892–9750, 240–276–6344, birdr@mail.nih.gov. E:\FR\FM\11JAN1.SGM 11JAN1 srobinson on DSK9F5VC42PROD with NOTICES 1378 Federal Register / Vol. 83, No. 8 / Thursday, January 11, 2018 / Notices Name of Committee: National Cancer Institute Special Emphasis Panel; Outstanding Investigator Award (OIA) II. Date: March 8–9, 2018. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878. Contact Person: Caron A. Lyman, Ph.D., Scientific Review Officer, Research Program Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W126, Bethesda, MD 20892–9750, 240–276–6348, lymanc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–9— Drug Development. Date: March 9, 2018. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W114, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W114, Bethesda, MD 20892– 9750, 240–276–6371, decluej@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; TEP–1: Development of Software Tools for Post Radiation Therapy Surveillance. Date: March 13–14, 2018. Time: 4:00 p.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Shakeel Ahmad, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W102, Bethesda, MD 20892– 9750, 240–276–6349, ahmads@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Emerging Questions in Cancer Systems Biology (U01). Date: March 16, 2018. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 2E908, Rockville, MD 20850. Contact Person: Timothy C. Meeker, MD, Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W606, Bethesda, MD 20892–9750, 240–276–6464, meekert@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer VerDate Sep<11>2014 00:05 Jan 11, 2018 Jkt 244001 Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: January 5, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–00297 Filed 1–10–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given for the meeting of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention National Advisory Council (CSAP NAC) on February 14, 2018. The Council was established to advise the Secretary, Department of Health and Human Services (HHS); the Assistant Secretary for Mental Health and Substance Use, SAMHSA; and Director, CSAP concerning matters relating to the activities carried out by and through the Center and the policies respecting such activities. The meeting will be open to the public and will include the discussion of the substance use prevention workforce and opioid use prevention. The meeting will also include updates on CSAP program developments. The meeting will be held in Rockville, Maryland. Attendance by the public will be limited to the space available. Interested persons may present data, information, or views, orally or in writing, on issues pending before the Council. Written submissions should be forwarded to the contact person on or before one week prior to the meeting. Oral presentations from the public will be scheduled at the conclusion of the meeting. Individuals interested in making oral presentations should notify the contact on or before one week prior to the meeting. Five minutes maximum will be allotted for each presentation. To attend onsite, submit written or brief oral comments, or request special accommodations for persons with disabilities, please register at the SAMHSA Committees’ website, https:// nac.samhsa.gov/Registration/ meetingsRegistration.aspx, or communicate with the CSAP Council’s PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 Designated Federal Officer (see contact information below). Substantive program information may be obtained after the meeting by accessing the SAMHSA Committee website, https://nac.samhsa.gov/, or by contacting the Designated Federal Officer. Committee Name: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention National Advisory Council. Date/Time/Type: February 14, 2018, from 9:30 a.m. to 4:30 p.m. EST: (OPEN). Place: SAMHSA, 5600 Fishers Lane, Room 5A02, Rockville, MD 20852, Adobe Connect webcast: https://samhsacsap.adobeconnect.com/nac/. Contact: Matthew J. Aumen, Designated Federal Officer, SAMHSA CSAP NAC, 5600 Fishers Lane, Rockville, MD 20852, Telephone: 240–276–2440, Fax: 301–480– 8480, Email: matthew.aumen@ samhsa.hhs.gov. Carlos Castillo, Committee Management Officer, SAMHSA. [FR Doc. 2018–00369 Filed 1–10–18; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF THE INTERIOR Fish and Wildlife Service [Docket No. FWS–HQ–IA–2017–0086; FXIA16710900000–178–FF09A30000] Foreign Endangered and Threatened Species; Receipt of Permit Applications Fish and Wildlife Service, Interior. ACTION: Notice of receipt of permit applications. AGENCY: We, the U.S. Fish and Wildlife Service, invite the public to comment on applications to conduct certain activities with foreign endangered and threatened species. With some exceptions, the Endangered Species Act prohibits activities with listed species unless Federal authorization is acquired that allows such activities. The ESA also requires that we invite public comment before issuing these permits. DATES: We must receive comments by February 12, 2018. ADDRESSES: Document availability: The applications, as well as any comments and other materials that we receive, will be available for public inspection online in Docket No. FWS–HQ–IA–2017–0086 at https://www.regulations.gov. Submitting comments: You may submit comments by one of the following methods: SUMMARY: E:\FR\FM\11JAN1.SGM 11JAN1

Agencies

[Federal Register Volume 83, Number 8 (Thursday, January 11, 2018)]
[Notices]
[Pages 1377-1378]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00297]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant and/or contract proposals applications 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant and/or 
contract proposals applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel TEP-9B: Cancer Cachexia Therapy.
    Date: February 6, 2018.
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Jun Fang, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W246, Bethesda, MD 20892-9750, 240-276-5460, 
[email protected].
    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Development of Informatics Technologies for Cancer Research 
and Management.
    Date: February 8-9, 2018.
    Time: 5:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Cambria Hotel & Suites Rockville, 1 Helen Henghan Way, 
Rockville, MD 20892.
    Contact Person: Saejeong J. Kim, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W640, Bethesda, MD 20892-9750, 240-276-5179, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Program Project V (P01) Review.
    Date: February 14-15, 2018.
    Time: 5:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 9751 
Washingtonian Boulevard, Gaithersburg, MD 20878.
    Contact Person: Wlodek Lopaczynski, MD, Ph.D., Scientific Review 
Officer, Office of the Director, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W514, Bethesda, MD 20892-9750, 240-276-6340, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Innovative Molecular Analysis Technologies (IMAT).
    Date: February 15, 2018.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Yasuko Furumoto, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W424, Bethesda, MD 20892-9750, 240-276-5287, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Pancreatic Cancer Detection Consortium (U01).
    Date: February 15, 2018.
    Time: 11:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W240, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Hasan Siddiqui, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH 9609, Medical Center Drive, Room 
7W240, Bethesda, MD 20892-9750, 240-276-5122, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-5A: NCI Clinical and Translational Exploratory/
Developmental Studies.
    Date: February 15, 2018.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W238, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W238, Bethesda, MD 20892-9750, 240-276-7755, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; UH2 Review.
    Date: February 27, 2018.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W608, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Robert E. Bird, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W608, Bethesda, MD 20892-9750, 240-276-6344, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; R25 Review.
    Date: February 28, 2018.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W608, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Robert E. Bird, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W608, Bethesda, MD 20892-9750, 240-276-6344, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; R01 Multi-Site.
    Date: March 6, 2018.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W608, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Robert E. Bird, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W608, Bethesda, MD 20892-9750, 240-276-6344, 
[email protected].


[[Page 1378]]


    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Outstanding Investigator Award (OIA) II.
    Date: March 8-9, 2018.
    Time: 8:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 9751 
Washingtonian Boulevard, Gaithersburg, MD 20878.
    Contact Person: Caron A. Lyman, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W126, Bethesda, MD 20892-9750, 240-276-6348, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-9--Drug Development.
    Date: March 9, 2018.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W114, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W114, Bethesda, MD 20892-9750, 240-276-6371, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-1: Development of Software Tools for Post Radiation 
Therapy Surveillance.
    Date: March 13-14, 2018.
    Time: 4:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Shakeel Ahmad, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W102, Bethesda, MD 20892-9750, 240-276-6349, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Emerging Questions in Cancer Systems Biology (U01).
    Date: March 16, 2018.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 2E908, Rockville, MD 20850.
    Contact Person: Timothy C. Meeker, MD, Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W606, Bethesda, MD 20892-9750, 240-276-6464, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: January 5, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-00297 Filed 1-10-18; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.